Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients

Canadian Journal of Infectious Diseases

Volumn 13, Issue 5, 2002, Pages 287-292

  Fung, Scott K ^a   Louie, Marie ^a   Simor, Andrew E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Department of Microbiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CHLORHEXIDINE GLUCONATE; COTRIMOXAZOLE; DOXYCYCLINE; FUSIDIC ACID; MINOCYCLINE; NOVOBIOCIN; PLACEBO; POLYSPORIN; PSEUDOMONIC ACID; RIFAMPICIN; SOAP;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAND WASHING; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

EID: 0036760410     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/567090     Document Type: Article

References (33)

1. Simor AE, Ofner-Agostini M, Bryce E, et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: The results of five years of national surveillance. CMAJ 2001;165:21-6.
2. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillinresistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999;29:797-800.
3. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillinresistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
4. Boyce JM, Jackson MM, Pugliese G, et al. Methicillin-resistant Staphylococcus aureus (MRSA): A briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994;15:105-15.
5. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: Analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993;17:466-74.
6. Hill RLR, Duckworth GJ, Casewell MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988;22:377-84.
7. Bertino JS. Intranasal mupirocin for outbreaks of methicillinresistant Staphylococcus aureus. Am J Health-Syst Pharm 1997;54:2185-91.
8. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-6.
9. Cederna JE, Terpenning MS, Ensberg M, Bradley SF, Kauffman CA. Staphylococcus aureus nasal colonization in a nursing home: Eradication with mupirocin. Infect Control Hosp Epidemiol 1990;11:13-6.
10. Roccaforte JS, Bittner MJ, Stumpf CA, Preheim LC. Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin. Am J Infect Control 1988;16:141-6.
11. Darouiche R, Wright C, Hamill R, Koza M, Lewis D, Markowski J. Eradication of colonization by methicillin-resistant Staphylococcu aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother 1991;35:1612-5.
12. Parras F, Guerrero C, Bouza E, et al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995;39:175-9.
13. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 5th Edn. Wayne: NCCLS M7-A5, 2000.
14. Louie L, Matsumura SO, Choi E, Louie M, Simor AE. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 2000;38:2170-3.
15. Simor AE, Boyd D, Louie L, McGeer A, Mulvey M, Willey BM. Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can J Infect Dis 1999;10:333-6.
16. Pearman JW, Christiansen KJ, Annear DI, et al. Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust 1985;142:103-8.
17. Walsh TJ, Vlahov D, Hansen SL, et al. Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control 1987;8:7-14
18. Dacre J, Emmerson AM, Jenner EA. Gentamicin-methicillinresistant Staphylococcus aureus: Epidemiology and containment of an outbreak. J Hosp Infect 1986;7:130-6.
19. Davies EA, Emmerson AM, Hogg GM, Patterson MF, Shields MD. An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: Value of topical mupirocin and of traditional methods of infection control. J Hosp Infect 1987;10:120-8.
20. Rao N, Jacobs S, Joyce L. Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol 1988;9:255-60.
21. Ward TT, Winn RE, Hartstein AI, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: Role of antimicrobial therapy in infection control. Infect Control 1981;2:453-9.
22. Ellison RT III, Judson FN, Peterson LC, Cohn DL, Ehret JM. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med 1984;140:735-40.
23. Valls V, Gómez-Herruz P, González-Palacios R, Cuadros JA, Romanyk JP, Ena J. Long-term efficacy of a program to control methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994;13:90-5.
24. Boyce JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46-54.
25. Cookson BD. The emergence of mupirocin resistance: A challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998;41:11-8.
26. Walsh TJ, Standiford HC, Reboli AC, et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprimsulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: Prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 1993;37:1334-42.
27. Chang S-C, Hsieh S-M, Chen M-L, Shen W-H, Chen Y-C. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains. Diagn Microbiol Infect Dis 2000;36:131-6.
28. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 1993;94:371-8.
29. Fung S, O'Grady S, Kennedy C, Dedier H, Campbell I, Conly J. The utility of Polysporin ointment in the eradication of methicillin-resistant Staphylococcus aureus colonization: A pilot study. Infect Control Hosp Epidemiol 2000;21:653-5.
30. Bacon AE, Jorgensen KA, Wilson KH, Kauffman CA. Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control 1987;8:145-50.
31. Strausbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT. Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit. Infect Control Hosp Epidemiol 1992;13:151-9.
32. Muder RR, Boldin M, Brennen C, et al. A controlled trial of rifampicin, minocycline, and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long term care patients. J Antimicrob Chemother 1994;34:189-90.
33. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000;31:1380-5.